Skip to content
OpenCapital
Get started

Acumen Pharmaceuticals, Inc. ABOS Q4 2024 Annual earnings

Reported March 27, 2025 · Before market open

Diluted EPS-$0.62Miss by $0.15
EPS estimate-$0.47

Next report

Aug 11, 2026 (In 4 weeks)
EPS estimate-$0.39

Versus estimates

Diluted EPS

Q1 2026-$0.33Beat by $0.07Q4 2025-$0.41Beat by $0.09Q3 2025-$0.44Beat by $0.19Q2 2025-$0.68Miss by $0.14Q1 2025-$0.48Beat by $0.08
Q4 2024-$0.62Miss by $0.15

Ask the moment Acumen Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Acumen Pharmaceuticals, Inc. report Q4 2024 earnings?
Acumen Pharmaceuticals, Inc. (ABOS) reported Q4 2024 earnings on March 27, 2025 before market open.
What were Acumen Pharmaceuticals, Inc.'s Q4 2024 revenue and EPS?
Acumen Pharmaceuticals, Inc. reported diluted EPS of $-0.62 for Q4 2024.
Did Acumen Pharmaceuticals, Inc. beat estimates in Q4 2024?
EPS missed the consensus estimate of $-0.47 by $0.15.
Where can I find Acumen Pharmaceuticals, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001576885-25-000049) directly on SEC EDGAR. The filing index links above go to sec.gov.